The reality of securing investment to scale alternative proteins
Sharyn Murray, CFAThe funding environment for alternative protein companies has shifted dramatically–but paths forward are emerging.
The funding environment for alternative protein companies has shifted dramatically–but paths forward are emerging.
New investment data and GFI analysis shows that the long-term outlook for alternative protein investment is strong, despite volatile market conditions.
First-of-their-kind frameworks raise the bar on sustainability reporting, increasing transparency of the environmental and social impacts of alt proteins and enabling direct comparisons with animal protein products.
Use this form to provide feedback on GFI and FAIRR’s Alternative Proteins ESG reporting frameworks and technical guides, or submit a case study.
Alternative proteins can help investors achieve their ESG and corporate citizenship goals while driving positive outcomes for people and the planet.
Considering investing in an alternative protein startup? Find support and resources here for conducting due diligence.
Sharyn Murray leads GFI's initiatives to bolster private-sector financing of the alternative proteins industry. Areas of expertise: strategic planning, public speaking, relationship development, investment research.